December 21, 2025 - 13:24

As 2026 approaches, affordability remains a dominant concern for Americans, with health insurance costs poised to rise sharply, especially in Florida. Government law attorney Chris Hand highlighted on a recent program that the impending expiration of COVID-era subsidies for the Affordable Care Act (ACA) could have severe consequences for many residents.
Approximately 1.5 million Floridians currently rely on these subsidies to help make their health insurance premiums manageable. The termination of this financial support is expected to result in increased out-of-pocket expenses for individuals and families, potentially forcing some to forgo necessary medical care.
Hand emphasized that the loss of these subsidies could disproportionately affect low- and middle-income households, exacerbating existing health disparities in the state. As the deadline approaches, advocates are urging policymakers to consider extending these vital subsidies to ensure that Floridians maintain access to affordable healthcare. The situation remains a critical issue as residents prepare for the upcoming changes in the health insurance landscape.
May 9, 2026 - 22:43
College of Pharmacy & Health Sciences confers 206 degrees - NewsThe Campbell University College of Pharmacy & Health Sciences held its spring commencement ceremony to honor the achievements of the Class of 2026. A total of 206 degrees were conferred during the...
May 9, 2026 - 02:40
California Becomes First State to Offer Free Diapers for Every NewbornCalifornia is set to launch a first-of-its-kind program that will provide free diapers to every newborn in the state. The initiative, which makes California the first state in the country to offer...
May 8, 2026 - 11:45
Maryland ranked high among states for public health preparedness, but could be doing moreMaryland continues to rank among the top states in the nation for its ability to handle public health emergencies, according to a recent analysis by a national health policy organization. The state...
May 7, 2026 - 18:47
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo NordiskThe arrival of the first generic versions of semaglutide in Canada is being watched closely as a potential turning point for Novo Nordisk`s dominance in the global weight-loss and diabetes market....